TMCI vs. GUTS, TCMD, SKIN, LUNG, TLSI, SGHT, INO, NVRO, ANGO, and UTMD
Should you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include Fractyl Health (GUTS), Tactile Systems Technology (TCMD), Beauty Health (SKIN), Pulmonx (LUNG), TriSalus Life Sciences (TLSI), Sight Sciences (SGHT), Inovio Pharmaceuticals (INO), Nevro (NVRO), AngioDynamics (ANGO), and Utah Medical Products (UTMD). These companies are all part of the "surgical & medical instruments" industry.
Fractyl Health (NASDAQ:GUTS) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, community ranking, valuation, analyst recommendations, institutional ownership, earnings and risk.
In the previous week, Treace Medical Concepts had 13 more articles in the media than Fractyl Health. MarketBeat recorded 22 mentions for Treace Medical Concepts and 9 mentions for Fractyl Health. Fractyl Health's average media sentiment score of 0.56 beat Treace Medical Concepts' score of -0.02 indicating that Treace Medical Concepts is being referred to more favorably in the news media.
Fractyl Health has a net margin of 0.00% compared to Fractyl Health's net margin of -27.93%. Treace Medical Concepts' return on equity of 0.00% beat Fractyl Health's return on equity.
Treace Medical Concepts has higher revenue and earnings than Fractyl Health.
Fractyl Health presently has a consensus target price of $22.00, suggesting a potential upside of 211.61%. Treace Medical Concepts has a consensus target price of $12.21, suggesting a potential upside of 144.29%. Given Treace Medical Concepts' stronger consensus rating and higher possible upside, analysts plainly believe Fractyl Health is more favorable than Treace Medical Concepts.
84.1% of Treace Medical Concepts shares are held by institutional investors. 24.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Treace Medical Concepts received 21 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 53.33% of users gave Treace Medical Concepts an outperform vote.
Summary
Fractyl Health beats Treace Medical Concepts on 8 of the 15 factors compared between the two stocks.
Get Treace Medical Concepts News Delivered to You Automatically
Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Treace Medical Concepts Competitors List
Related Companies and Tools
